Randy Teel
CEO, President & DirectorDr. Randy Teel, Ph.D. served as Interim Chief Financial Officer and Treasurer at Arvinas, Inc. since February 29, 2024 until April 2024 and served as its Chief Business Officer since April 2024 until February 12, 2026. He serves as CEO, President and Director at Arvinas, Inc. since February 12, 2026 and served as its Senior Vice President of Corporate and Business Development since September 2021 until February 29, 2024 and also had been Vice President of Corporate Development since May 2018 until September 2021. Prior to joining Arvinas, Inc. Dr. Teel served as the Vice President, Corporate Strategy at Alexion Pharmaceuticals, Inc. from February 2015 to December 2017. Previously, Dr. Teel was an Associate Partner at McKinsey & Company, a management consulting firm, from February 2008 to February 2015. Dr. Teel holds a Ph.D. in immunobiology from Yale University and a B.S. in biology from Gonzaga University.
Positions
- Company NameArvinas, Inc.Stock CodeARVNPositionCEO, President & DirectorColleagues
- ARAndrew R. SaikCFO & Treasurer
- BDBriggs Duncan W. MorrisonIndependent Chairman & Lead Director
- AMAngela M. CacaceChief Scientific Officer
- DKDavid K. LoomisVP & Chief Accounting Officer
- JBJeff BoyleVice President of Investor Relations
- ITIan TaylorChairman of Scientific Advisory Board
- EMEdward Moore KennedyIndependent Director
- LVLeslie V. NorwalkIndependent Director
